Clinical trial
Registration of Oral Hedgehog Inhibitors Vismodegib and Sonidegib in the Treatment of Advanced and Multiple Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study.
NCT05463757 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Registration of Oral Hedgehog Inhibitors Vismodegib and Sonidegib in the Treatment of Advanced and Multiple Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study.
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 1, 2021
- Completion date
- December 31, 2026
- Enrollment
- 80 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
basal cell carcinoma, basal cell nevus syndrome, basal cell tumor, carcinoma, carcinoma, basal cell, gorlin syndrome, locally advanced basal cell carcinoma, metastatic basal cell carcinoma, neoplasm of skin, neoplasms, basal cell, skin cancer